Despite the negative impact of COVID-19 pandemic on elimination hepatitis C virus (HCV), use mass testing for SARS-CoV-2 might represent a glimmer opportunity to increase HCV diagnostic capacities. Processing tests has created an enormous workload laboratories worldwide and resulted in decreased processing many other tests, such as those infection. Diagnosis active infection is necessary first ...